ProMIS Neurosciences is trading at $14.42 (up 5%) in what appears to be a continuation of a technical rebound following sharp recent swings and profit-taking.
- The stock has experienced significant volatility over the past week, previously pressured by broader biotech sector softness.
- Shares are currently catching a bid as market risk sentiment improves, with major U.S. indices trading more than 1% higher.